STEMIRNA
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.
STEMIRNA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-05-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.stemirna.com
Total Employee:
11+
Status:
Active
Contact:
(400)888-8888
Email Addresses:
[email protected]
Total Funding:
1.33 B CNY
Technology used in webpage:
Euro SPF Pound Sterling Microsoft Azure DNS Japanese Yen Alibaba China Telecom
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
CITIC Securities
CITIC Securities investment in Series C - Stemirna
GreatWall Fund
GreatWall Fund investment in Series C - Stemirna
Greenwoods Investment
Greenwoods Investment investment in Series C - Stemirna
Oceanpine Capital
Oceanpine Capital investment in Series C - Stemirna
Tibet AIM Pharm
Tibet AIM Pharm investment in Series C - Stemirna
Renjin Investment
Renjin Investment investment in Series C - Stemirna
Beijing Shenzhen Sai Fund
Beijing Shenzhen Sai Fund investment in Series C - Stemirna
OrbiMed
OrbiMed investment in Series C - Stemirna
Tsing Capital
Tsing Capital investment in Series C - Stemirna
WuXi AppTec
WuXi AppTec investment in Series C - Stemirna
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-12 | StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer |
Official Site Inspections
http://www.stemirna.com
- Host name: 120.78.166.66
- IP address: 120.78.166.66
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Stemirna"
Stemirna - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Stemirna Company Profile - Office Locations, Competitors ... - Craft
Feb 10, 2020 Stemirna is an RNA technology-based drug development company. It works on mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, …See details»
Stemirna Therapeutics Co., Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Stemirna Therapeutics Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 2 news, and 6 literature, Disease Domain:Infectious Diseases, …See details»
Stemirna Therapeutics - VentureRadar
As the first biotech company in China to focus on mRNA therapeutics, Stemirna strives to deliver novel cure for patients in the world. Taking advantage of its two innovative mRNA platforms – …See details»
Stemirna - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of Stemirna includes 15 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. Additionally, Stemirna has 1 registered trademark …See details»
Stemirna Therapeutics - Golden
Stemirna Therapeutics was founded in the Zhangjiang Drug Valley of Shanghai, in 2016. Now it is located in the Jinqiao Pilot Free Trade Zone. Now it is located in the Jinqiao Pilot Free Trade …See details»
Stemirna Therapeutics Co., Ltd. (斯微（上海）生物科技股份有限公 …
了解Stemirna Therapeutics Co., Ltd. (斯微（上海）生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验, 6篇新闻和6篇文献，疾病领域:感染，肿瘤，神经系 …See details»
Stemirna Therapeutics, Once a Leading mRNA Developer in China, …
Oct 15, 2024 Stemirna Therapeutics Co., Ltd, a one-time leading mRNA developer in China, has officially commenced bankruptcy proceedings, with the case accepted by the Pudong New …See details»
StemiRNA Therapeutics Biotech - PitchBook
Feb 21, 2020 StemiRNA Therapeutics Biotech General Information Description. Developer of mRNA technology-based drug designed for the medical field. The company's independently …See details»
Stemirna Therapeutics (Usa Co. Ltd.: Drug pipelines, Patents, …
Feb 8, 2024 Explore Stemirna Therapeutics (Usa Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Stemirna - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Stemirna . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Stemirna has 1 …See details»
China’s mRNA Vaccine Developer Stemirna Secures $200 Million in …
Jun 4, 2021 Founded by a group of Chinese scholars in Shanghai's Zhangjiang Drug Valley, China-based Stemirna Therapeutics (Stemirna) announced the completion of a new funding …See details»
Stemirna Raises $200 Million Round of Financing, CEC Capital …
Jun 3, 2021 Stemirna has independently developed a cloud computing-based platform for antigen analysis, prediction, and sequence optimization. The company also boasts a …See details»
Stemirna Therapeutics | VentureRadar
As the first biotech company in China to focus on mRNA therapeutics, Stemirna strives to deliver novel cure for patients in the world. Taking advantage of its two innovative mRNA platforms – …See details»
Shanghai's Stemirna Raises $14 Million for RNA Drug Development
Aug 12, 2019 Stemirna Therapeutics, a Shanghai RNA biopharma, raised nearly $14 million in a Series A financing. Founded in 2016 by a group of returning PhDs from MD Anderson Cancer …See details»
Stemirna - Updates, News, Events, Signals & Triggers - Crunchbase
Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. Search Crunchbase. Start Free Trial . Chrome …See details»
Stemirna COVID-19 vaccine - Wikipedia
Stemirna Therapeutics raised a total of 1.2 Billion RMB (Renminbi) which translates to a little less than 200 million US Dollars for the start of their production and testing trials [5]. Li Hangwen, a …See details»
China’s mRNA pioneer Stemirna faces post-Covid reinvention test
Nov 2, 2023 Then on Aug. 24, Stemirna announced a direction shift, saying it would reposition itself as an mRNA development partner for the pharmaceutical industry. The company aims to …See details»
China's Stemirna raises $188M to fund mRNA COVID-19 vaccine
Jun 4, 2021 China’s Stemirna Therapeutics has raised RMB 1.2 billion ($188 million) to bankroll development of an mRNA vaccine against COVID-19. Sequoia Capital China co-led the …See details»